STAT5A and chronic myelogenous leukemia, BCR-ABL1 positive: In chronic myeloid leukemia (CML), STAT5A upregulated the expression level of miR-202–5p, which in turn inhibited USP15 expression to reduce Caspase-6 level and thereby lowered the apoptotic rate in CML cells [47].